Researchers at Pebble Biotechnology Laboratories have mapped every drug studied in small-rodent models of physical trauma between 1980 and 2020 against its regulatory outcome in humans. Across 5,033 studies and 333 drugs, no new trauma medicine reached approval as a result of that work. A companion systematic review in PLOS ONE reports that 3 of 83 drugs tested in rodent acute injury models achieved first-in-class approval for the tested indication.

A randomized clinical trial found that supervised physical therapy after anterior cruciate ligament (ACL) surgery) yielded greater improvements in pain, function, and muscle strength compared to a self-directed exercise program, at least in the short term.

Specialized high-fat, low carbohydrate diets, known as ketogenic metabolic therapy, are showing promising therapeutic benefits for certain mental illnesses in emerging research. Now, a new study from researchers at the University of Maryland School of Medicine’s Maryland Psychiatric Research Center (MPRC) shows that an immersive training program can improve health care provider confidence in using a ketogenic dietary treatment plan for their patients.

As Florida considers dropping its measles, mumps and rubella (MMR) vaccine mandate for school attendance, a new University of Maryland study predicts that such a policy change could spark the largest measles epidemic in the United States in nearly 50 years.

The health consequences of catastrophic wildfires that burn through towns and cities may extend far beyond the period when flames are extinguished and smoke disappears, according to new research from the University of Hawaiʻi at Mānoa’s Maui Wildfire Exposure Study (MauiWES).

These comprehensive advancements allow Ochsner to better accommodate the evolving healthcare requirements of the Capital Region community.

Zhen Xu, University of Michigan Engineering professor and a co-inventor of the soundwave-based cancer treatment histotripsy, has been named a 2026 recipient of the Golden Goose Award. 

The study reveals trends in health spending, which soared to nearly $65 billion in 2023 for the popular weight-loss drugs. Among their findings: Nearly 1 in 5 of GLP-1 users spent at least 10% of their household income on the medications.